Clinical Trial Update: Cardiovascular Inflammation Reduction Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a cardiovascular inflammation reduction study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Cardiovascular Disease | Phase 3 | Status: COMPLETED | Results posted: 2020-07-24